| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |